Ryvu Therapeutics Sa
Clinical trials sponsored by Ryvu Therapeutics Sa, explained in plain language.
-
New combo therapy aims to shrink spleens in Hard-to-Treat myelofibrosis
Disease control Recruiting nowThis study tests an experimental drug called RVU120 in adults with intermediate or high-risk myelofibrosis, a type of bone marrow cancer. Participants will receive RVU120 alone or together with the standard drug ruxolitinib. The main goal is to see if the treatment can shrink the…
Phase: PHASE2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
New hope for tough lymphoma: drug combo trial opens
Disease control Recruiting nowThis study tests a new drug, MEN1703, alone or with another drug (glofitamab) in adults with aggressive B-cell lymphoma that has come back or not responded to at least two prior treatments. The goal is to see if the treatment is safe and shrinks tumors. About 178 participants wil…
Phase: PHASE2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC